FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) is an insurtech company operating at the intersection of epigenetic science and life insurance underwriting. The company completed its business combination in September 2022 through a merger with Delwinds Insurance Acquisition Corp., a blank-check vehicle whose SPAC IPO priced in 2021, with the Delwinds sponsor group serving as the originating sponsor. FOXO's core platform applies saliva-based biomarker and longevity science data to modernize life insurance product development and distribution. The company filed an 8-K with the Securities and Exchange Commission on July 29, 2026, accession number 0001493152-26-035110, reflecting continued post-merger public reporting obligations. For full filing history, sponsor details, and real-time SPAC data on FOXO and hundreds of other transactions, sign up for SpacDesk at spacdesk.com.